MHC class I manipulation on cell surfaces by gene transfer of anti-MHC class I intrabodies - a tool for decreased immunogenicity of allogeneic tissue and cell transplants

被引:19
|
作者
Busch, A
Marasco, WA
Doebis, C
Volk, HD
Seifert, M
机构
[1] Humboldt Univ, Sch Med, Dept Med Immunol, D-10098 Berlin, Germany
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
关键词
intrabodies; antibodies intracellular; major histocompatibility antigen class I; tissue engineering; transfection; fusionprotein; bicistronic expression;
D O I
10.1016/j.ymeth.2004.03.017
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Intrabodies (IB) are suitable tools to down-regulate the expression of cell surface molecules in general. In this work, the appearance of major histocompatibility (MHC) class I molecules on the cell surface could be prevented by the expression of intracellularly localized anti-MHC class I antibodies. The expression of MHC antigens presenting intracellularly synthetised peptides on the cell surface is the predominant reason for immunologic detection and rejection of allogeneic cell and tissue transplants. Allogeneic keratinocyte sheets might be a suitable tool for skin grafting. Within this study primary rat keratinocytes have been transfected with anti-MHC I-IB. Strong IB-expressing cells showed a MHC I "knockout" phenotype. The cells did not exhibit any significant alterations compared to non-transfected cells: the cell growth and the expression of other surface molecules were unaltered. Merely an enhanced intracellular accumulation of MHC I molecules could be detected. Notably, IB-expressing keratinocytes displayed a reduced susceptibility to allogeneic cytotoxic T cells in vitro compared to unmodified cells with a normal level of MHC I surface expression. These MHC I-deficient keratinocytes might be utilized in tissue-engineered allogeneic non-immunogeneic skin transplants. The principle of MHC class I manipulation in general can be used for other allogeneic cell and tissue-engineered transplants as well. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:240 / 249
页数:10
相关论文
共 50 条
  • [1] MHC class I deficiency on endothelial cells by gene transfer of anti-MHC I intrabodies
    Doebis, C
    Beyer, F
    Busch, A
    Marasco, WA
    Volk, HD
    Seifert, M
    GENES AND IMMUNITY, 2003, 4 : S12 - S12
  • [2] The Forgotten Cell: Renal Fibroblasts Are Activated By Anti-MHC Class I Antibody
    Chen, J.
    Zmijewska, A.
    Mannon, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [3] Altered allogeneic response in neonatally anti-MHC class I-treated mice
    MarusicGalesic, S
    Sparbier, K
    Knezevic, N
    Walden, P
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (03) : 321 - 328
  • [4] ABROGATION OF ISLET IMMUNOGENICITY USING AN ANTI-MHC CLASS-I MONOCLONAL-ANTIBODY
    MUNN, SR
    MARJORIBANKS, C
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (03) : 1038 - 1039
  • [5] Decline of surface MHC I by adenoviral gene transfer of anti-MHC I intrabodies in human endothelial cells - new perspectives for the generation of universal donor cells for tissue transplantation
    Beyer, F
    Doebis, C
    Busch, A
    Ritter, T
    Mhashilkar, A
    Marasco, WM
    Laube, H
    Volk, HD
    Seifert, M
    JOURNAL OF GENE MEDICINE, 2004, 6 (06): : 616 - 623
  • [6] Role of Anti-MHC Class I Antibody in Facilitating Transplant Accommodation
    Atz, Mary E.
    Reed, Elaine F.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2008, 28 (06) : 485 - 511
  • [7] Multifaceted roles of MHC class I and MHC class I–like molecules in T cell activation
    Sophie Ugolini
    Eric Vivier
    Nature Immunology, 2001, 2 : 198 - 200
  • [8] Multifaceted roles of MHC class I and MHC class I-like molecules in T cell activation
    Ugolini, S
    Vivier, E
    NATURE IMMUNOLOGY, 2001, 2 (03) : 198 - 200
  • [9] The cell biology of MHC class I antigen presentation
    Williams, A
    Peh, CA
    Elliott, T
    TISSUE ANTIGENS, 2002, 59 (01): : 3 - 17
  • [10] MHC Class I Silencing Increases Graft Survival after Allogeneic Cell Transplantation
    Figueiredo, C.
    Wedekind, D.
    Mueller, T.
    Vahlsing, S.
    Horn, P. A.
    Seltsam, A.
    Blasczyk, R.
    TRANSPLANTATION, 2012, 94 (10) : 477 - 477